Carcinoids and large cell neuroendocrine carcinomas (LCNECs) are rare neuroendocrine
lung tumors. Here we provide an overview of the most updated data on the molecular …

Lung cancer shows substantial genetic and phenotypic heterogeneity across individuals,
driving a need for personalised medicine. Here, we report lung cancer organoids and …

Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare and highly aggressive
type of lung cancer, with a complex biology that shares similarities with both small-cell lung …

Pulmonary large-cell neuroendocrine carcinomas (LCNECs) have similarities with other
lung cancers, but their precise relationship has remained unclear. Here we perform a …

Purpose: The optimal systemic treatment for pulmonary large-cell neuroendocrine
carcinoma (LCNEC) is still under debate. Previous studies showed that LCNEC with …

Background Large cell neuroendocrine carcinoma (LCNEC) accounts for approximately 3%
of lung cancers. Pathologic classification and optimal therapies are debated. We report the …

Pulmonary large cell neuroendocrine carcinoma (LCNEC) is rare. Chemotherapy for
metastatic LCNEC ranges from small cell lung carcinoma (SCLC) regimens to nonsmall cell …

Large-cell neuroendocrine carcinomas of the lung (LCNECs) are rare tumors representing 1–
3% of all primary lung cancers. Patients with LCNEC are predominantly male, older, and …

Introduction Large-cell neuroendocrine carcinoma (LCNEC) accounts for approximately 3%
of lung malignancies. There are limited data on the epidemiology and best treatment …

Twelve lung neuroendocrine tumors with morphologic features of carcinoid tumors but with
mitotic count> 10/2 mm 2 are reported. There were 7 males and 5 females, with age ranging …